CDER Adds Gaucher Disease to 2017 Guidance Agenda Post author:Sam Post published:April 20, 2017 Post category:Drug Industry Daily CDER updated its guidance agenda for 2017, adding an item on Gaucher Disease. Source: Drug Industry Daily You Might Also Like FDA Releases Four Guidances on Topical Generics October 21, 2022 FDA’s Clinical Decision Software Guidance Violates First Amendment, Petitioner Says July 12, 2023 Sales of Customized Dietary Supplements Blocked by Federal Judge October 16, 2017
